Task: Answer the multiple-choice question.
Question: Which drug exhibits a 1.683\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
(a) CCOCCCNC(=O)C(NC(=O)c1ccc(=O)[nH]c1)c1ccccc1
(b) CSc1ccccc1NC(=O)c1cnc2scc(C)n2c1=O
(c) CCCCN(C)C(=O)c1sc2ncn(CC)c(=O)c2c1C
(d) O=C(c1cccn2c(=O)c3ccccc3nc12)N1CCC2(CC1)OCCO2
Answer: c. CCCCN(C)C(=O)c1sc2ncn(CC)c(=O)c2c1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCCN(C)C(=O)c1sc2ncn(CC)c(=O)c2c1C
CCCCN(C)C(=O)c1sc2ncn(CC)c(=O)c2c1C
N-butyl-3-ethyl-N,5-dimethyl-4-oxothieno[2,3-d]pyrimidine-6-carboxamide